LIC announced on Thursday that it had sold 2 percent of its stake in Sun Pharma for Rs 4,699 crore in an open market transaction.
Following the share sale, there is a decrease of 2 percent decline in holding between July 22, 2022, and September 13, 2023.
In a regulatory filing, LIC stated, “Corporation’s shareholding in Sun Pharma has diluted from 12,05,24,944 to 7,22,68,890 equity shares decreasing its shareholding from 5.023 percent to 3.012 percent of the paid-up capital of the said company”.
“The shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction”, LIC added.
Sun Pharma manufactures, develops, and markets a diverse range of branded and generic formulations, as well as Active Pharma Ingredients (APIs).
LIC, the country’s largest state-owned insurer, finished at Rs 660.80 per share on BSE, up 0.27 percent. Sun Pharma shares closed 0.8 percent higher at Rs 1,143.60.
Also read: Maruti Suzuki Collaborates With Indian Bank To Offer Dealers Financing Options
Indian cricket team captain Rohit Sharma dedicated the T20 World Cup trophy to the entire…
The court highlighted that unauthorized constructions are blocking water outlets, leading to clogged drains and…
Following Justice Mridul's transfer to the Manipur High Court, the case was reassigned to Justices…
The unfolding saga surrounding Kingdon Capital's financial strategies and Adani Group's defenses against allegations highlight…
The city of Mumbai came alive with fervor and enthusiasm, celebrating the historic T20 World…
Fans, eager to celebrate India's first ICC T20 World Cup title, thronged the route, creating…